Caris Life Sciences Inc.

NASDAQ: CAI · Real-Time Price · USD
35.07
-1.86 (-5.04%)
At close: Aug 20, 2025, 3:59 PM
35.42
1.00%
After-hours: Aug 20, 2025, 07:43 PM EDT

Caris Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
47.03M 38.81M 47.91M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
851.9M 800.21M 661.54M
Receivables
190.81M 166.1M 152.77M
Inventory
n/a n/a n/a
Other Current Assets
4.75M 6M 6.39M
Total Current Assets
242.59M 210.92M 207.07M
Property-Plant & Equipment
2.17B 1.94B 1.81B
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
3.02B 2.74B 2.47B
Total Assets
3.27B 2.96B 2.68B
Account Payables
3.44M 4.38M 3.23M
Deferred Revenue
9.72M 2.44M 3.26M
Short-Term Debt
161.75M 116.43M 183.88M
Other Current Liabilities
163.58M 343.79M 88.15M
Total Current Liabilities
338.49M 467.04M 278.52M
Long-Term Debt
2.1B 1.71B 1.64B
Other Long-Term Liabilities
2.43M 2.99M 3.47M
Total Long-Term Liabilities
2.13B 1.73B 1.67B
Total Liabilities
2.47B 2.2B 1.95B
Total Debt
2.26B 1.82B 1.83B
Common Stock
2K 2K 2K
Retained Earnings
605.94M 562.2M 531.66M
Comprehensive Income
175K 96K 1.37M
Shareholders Equity
800.72M 756.26M 726.21M
Total Investments
n/a n/a n/a